Welcome to our dedicated page for Nature’S Sun SEC filings (Ticker: NATR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. SEC filings for Nature’s Sunshine Products, Inc. (NASDAQ: NATR), a natural health and wellness company that manufactures and distributes herbal, nutritional and personal care products. As a registrant on the Nasdaq Capital Market, Nature’s Sunshine files periodic and current reports that describe its operations, financial condition, risk factors and material corporate events.
Through this filings feed, readers can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include segment information for Asia, Europe, North America and Latin America & Other, along with discussions of gross margins, selling, general and administrative expenses, adjusted EBITDA and the impact of foreign currency. These reports also incorporate detailed risk factor disclosures related to government regulation, direct selling, independent consultants, product liability, supply chain disruptions, cybersecurity, data privacy and tax matters.
Nature’s Sunshine also uses current reports on Form 8-K to announce material events. Recent 8-K filings have covered quarterly financial results, executive leadership changes such as the appointment of a new Chief Executive Officer, secondary public offerings by a selling stockholder, share repurchase agreements, and share purchase agreements to acquire interests in joint ventures in Hong Kong and Shanghai. These filings often reference non-GAAP measures and include reconciliations in attached exhibits.
Investors can also monitor registration statements and prospectus supplements related to offerings of common stock, as well as agreements tied to concurrent share repurchases. Where applicable, Form 4 and other insider transaction reports provide additional insight into trading activity by directors and officers.
On Stock Titan, AI-powered tools summarize lengthy filings, highlight key changes from prior periods and surface important items such as segment performance, capital allocation decisions, material contracts and governance updates. Real-time ingestion from EDGAR helps ensure that new NATR filings, including 10-Ks, 10-Qs, 8-Ks and ownership reports, are available quickly with plain-language explanations to support deeper research into Nature’s Sunshine’s regulatory and financial disclosures.
Nature’s Sunshine Products reported record 2025 results with strong growth in sales and profitability. Full-year net sales rose 5.7% to $480.1 million, while GAAP net income attributable to common shareholders increased to $19.5 million, or $1.06 per diluted share, from $7.7 million, or $0.40 per diluted share. Adjusted EBITDA grew 21.7% to $49.4 million.
Fourth-quarter net sales rose 4.7% to $123.8 million and GAAP EPS improved to $0.23 from a loss of $(0.02). Q4 adjusted EBITDA increased 16% to $11.9 million. Growth was driven by stronger digital channels and solid performance in North America and key international markets, alongside higher gross margins.
The company ended 2025 with $93.9 million in cash and cash equivalents and no outstanding debt, after repurchasing 1,260,000 shares for $16.3 million. For 2026, it projects net sales between $500 million and $515 million and adjusted EBITDA between $50 million and $54 million. The filing also notes modest base salary increases for the CFO and Executive Vice President, Asia.
Natures Sunshine Products Inc executive Nathan Brower, EVP and General Counsel, reported an in-kind charitable donation of 1,500 common shares of company stock.
The shares were transferred on November 24, 2025 at a reported price of $20.56 per share, the volume-weighted average price that day, and he now holds 45,235 shares directly. The donation was made for charitable purposes and no consideration was received.
Natures Sunshine Products executive Bryant J. Yates reported a disposition of 1,700 common shares on December 12, 2025 at $22.29 per share. After this transaction, he directly owns 98,604 common shares of the company. Yates is listed as Executive Vice President and President, Europe, and the report covers a transaction by a single reporting person.
Nature's Sunshine Products (NATR) executive Daniel C. Norman, EVP & President, Asia, reported two transactions in company common shares. On 11/12/2025, he sold 8,884 common shares at a weighted average price of $20.46 per share, with individual trades ranging from $20.08 to $21.20. On 11/17/2025, he transferred 3,571 common shares as an in-kind charitable donation, for which no consideration was received; the stated price of $20.79 per share reflects the volume-weighted average trading price that day. After these transactions, he beneficially owned 63,065 common shares directly.
Natures Sunshine Products, Inc. (NATR) reported an insider stock transaction by its Senior Vice President and Chief Accounting Officer, Jonathan D. Lanoy. On 11/18/2025, he sold 5,000 common shares of NATR in an open-market transaction coded "S" for sale at a price of $20.45 per share. After this transaction, he beneficially owned 46,233 common shares, held directly. The filing was made on Form 4, which is used to disclose changes in ownership by company insiders.
Natures Sunshine Products Inc. (NATR) reported an insider stock transaction by its EVP and General Counsel, Nathan Brower. On 11/14/2025, he sold 3,800 common shares of NATR at a price of $20.81 per share, in a transaction coded as a sale. After this trade, he beneficially owns 46,735 common shares directly. This filing reflects a personal portfolio move by a senior executive and does not by itself describe any change in the company’s operations or financial performance.
Nature’s Sunshine Products (NATR) reported stronger Q3 2025 results, with net sales of $128.3 million, up 12% year over year (10.5% in local currencies). Gross margin expanded to 73.3% from 71.3%, reflecting cost savings, market mix and favorable FX. Operating income rose to $9.0 million from $5.3 million, and diluted EPS increased to $0.30 from $0.23.
Growth was broad-based: Asia +17.1%, Europe +12.7%, and North America +7.7%, while Latin America and Other declined 13.1%. FX added about $1.7 million to quarterly sales. The effective tax rate was 42.8% in the quarter. Cash and cash equivalents were $95.6 million with no borrowings outstanding on the $25.0 million revolver. Year to date, operating cash flow was $25.4 million.
Through September 30, the company repurchased 1,129,000 shares for $14.4 million, leaving $19.3 million available under the program. The company entered agreements to purchase its partners’ interests in two China joint ventures for $3.9 million and $3.1 million, subject to PRC approvals. The company submitted voluntary self-disclosures to BIS and OFAC related to past trade controls compliance; items involved less than 1% of net revenue, and potential outcomes may include fines.
Nature’s Sunshine Products, Inc. filed an 8-K announcing it issued a press release with financial results for the first quarter ended September 30, 2025. The release was furnished under Item 2.02 and is attached as Exhibit 99.1.
The company notes the press release includes non-GAAP financial information, with GAAP-to-non‑GAAP reconciliations provided in the release. The information furnished under Item 2.02 is not deemed filed under the Exchange Act.
Nature’s Sunshine Products (NATR) officer Martin A. Gonzalez (EVP, Global Supply Chain) reported RSU-related share activity on 11/04/2025. Two tranches vested and were added at $0 per share via code M: 2,885 shares from a 07/21/2022 performance grant and 2,910 shares from a 04/20/2023 performance grant, each tied to an adjusted EBITDA milestone of $46.2M over a rolling 12 months. To cover taxes (code F), the company withheld 833 and 840 shares at $13.75. Following these transactions, beneficial ownership was 69,640 common shares (direct).
Nature's Sunshine Products (NATR) executive Nathan Brower, EVP and General Counsel, filed a Form 4 reporting equity transactions on 11/04/2025. The filing shows RSU vesting tied to an adjusted EBITDA milestone of $46.2M, resulting in acquisitions of 1,008 and 2,235 common shares at $0.
To cover taxes upon vesting, the company withheld 285 and 700 shares at a price of $13.75. The transactions were reported as Direct ownership and filed by one reporting person.